Document is current
Any future updates will be listed below
-
Authors
Josephs, Keith A. https://orcid.org/0000-0003-2930-8634
Duffy, Joseph R.
Clark, Heather M.
Utianski, Rene L.
Strand, Edythe A.
Machulda, Mary M.
Botha, Hugo https://orcid.org/0000-0003-4390-685X
Martin, Peter R. https://orcid.org/0000-0002-2244-6412
Pham, Nha Trang Thu
Stierwalt, Julie
Ali, Farwa
Buciuc, Marina
Baker, Matthew
Fernandez De Castro, Cristhoper H.
Spychalla, Anthony J.
Schwarz, Christopher G. https://orcid.org/0000-0002-1466-8357
Reid, Robert I. https://orcid.org/0000-0003-2391-8650
Senjem, Matthew L.
Jack, Clifford R. Jr https://orcid.org/0000-0001-7916-622X
Lowe, Val J.
Bigio, Eileen H.
Reichard, Ross R.
Polley, Eric. J.
Ertekin-Taner, Nilufer
Rademakers, Rosa
DeTure, Michael A.
Ross, Owen A. https://orcid.org/0000-0003-4813-756X
Dickson, Dennis W. https://orcid.org/0000-0001-7189-7917
Whitwell, Jennifer L.
- License Information
-
More Information
Article History
Received: 28 January 2021
Accepted: 11 May 2021
First Online: 8 June 2021
Competing interests
: C.R.J. serves on an independent data monitoring board for Roche, has consulted for and served as a speaker for Eisai, and consulted for Biogen, but he receives no personal compensation from any commercial entity. V.J.L. is a consultant for AVID Radiopharmaceuticals, Eisai Co. Inc., Bayer Schering Pharma, GE Healthcare, and Merck Research, and receives research support from GE Healthcare, Siemens Molecular Imaging, and AVID Radiopharmaceuticals. M.L.S. owns stocks in Align Technology, Inc., Inovio Pharmaceuticals Inc., LHC Group, Inc., Mesa Laboratories, Inc., Natus Medical Inc., and Varex Imaging Corporation. All other authors declare no competing interests.
